Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
PolyNovo Ltd (PNV AU)
Watchlist
128
Analysis
Health Care
•
Australia
PolyNovo Limited is a biotechnology company. The Company has a portfolio of biodegradeable polymers that have potential for application across numerous medical fields.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
PolyNovo Ltd
•
29 Aug 2023 18:22
PolyNovo (PNV AU): FY23 Result- Sales Momentum Accelerates; Net Loss Widens on Higher Opex
PolyNovo reported record high sales of A$66.5M, up 59% YoY in FY23, driven by strong US momentum. However, net underlying loss widened due to...
Tina Banerjee
Follow
484 Views
Share
bullish
•
PolyNovo Ltd
•
15 Mar 2023 07:03
Australia: S&P/ASX, REMX, GDXJ, MVA, MVW, Other Flows on Friday
Implementation of the S&P/ASX, REMX, GDXJ, MVA and other indices take place at the close on Friday. There will be a lot of passive flow going...
Brian Freitas
Follow
636 Views
Share
bullish
•
Life360 Inc
•
05 Mar 2023 09:00
S&P/ASX Index Rebalance (Mar 2023): Big Impact Changes as Adds Outperform Deletes
There are 19 adds and 16 deletes across the S&P/ASX family of indices. On the larger names, passives need to buy 7-20x ADV while selling between 1...
Brian Freitas
Follow
834 Views
Share
bullish
•
PolyNovo Ltd
•
16 Feb 2023 05:54
S&P/ASX Index Rebalance Preview: Review Period (Nearly) Complete
We forecast 1 change for the ASX20, 2 for the ASX100, 4 for the ASX 200 & 10 adds/7 deletes for the ASX300 in March. Adds have outperformed deletes...
Brian Freitas
Follow
856 Views
Share
bullish
•
PolyNovo Ltd
•
30 Jan 2023 09:46
S&P/ASX Index Rebalance Preview: High Impact Changes in March
We currently see 1 change for the ASX20, 2 for the ASX100, 4 changes for the ASX 200 and 9 adds/ 6 deletes for the ASX300 Index in March. Lots of...
Brian Freitas
Follow
974 Views
Share
First
Previous
15
16
17
18
19
20
21
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x